Announcement on the achievement of the unlocking conditions of the third phase of Henan Lingrui Pharmaceutical's restricted stock incentive plan for 2021.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.